According to a new market research study of “Transdermal Drug Delivery System Market to 2027 – Global Analysis and Forecast by Type, Application, and End User,” the global transdermal drug delivery system market is expected to reach US$ 8,415.04 million in 2027 from US$ 6,063.85 million in 2019. The market is estimated to grow at a CAGR of 4.3% from 2020 to 2027. The report highlights trends prevailing in the global transdermal drug delivery system market and the factors driving market along with those that act as hindrances.
Transdermal Drug Delivery System (TDDS) is described as a self-contained or discrete dosage form known as patches or semisolid forms that are applied to the intact skin. There are different types of semisolid forms, such as, creams, ointments, gels, and sprays. Dosage forms are designed to deliver a therapeutically effective amount of drug across a patient’s skin.
Request Sample PDF Brochure – https://www.theinsightpartners.com/sample/TIPRE00002894/
Based on application, the global transdermal drug delivery system market is segmented into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The hormonal segment is further sub segmented into transdermal estrogen therapy and testosterone replacement therapy. In 2019, the pain management segment held the largest share of the global transdermal drug delivery system market and continued to register the highest CAGR of 5.0% in the market during the forecast period. The pain management segment is expected to grow owing to increasing number of transdermal drug delivery systems for the pain management and is likely to boost the growth of pain management application segment during the forecast period. For instance, in October 2015, Endo Pharmaceuticals Inc. received FDA approval for its new buccal film patch for the treatment of inner cheek pain. The patch was introduced to the market in 2016. Furthermore, in August 2018, Cipla got FDA approval for its Diclofenac Sodium Topical Gel for the treatment of pain in osteoarthritis of joints such as knees and hands.
Key Players –
Market leaders operating in the market have undertaken various organic growth strategies in the transdermal drug delivery system Market. The transdermal drug delivery system market majorly consists of the players such as Novartis Ag, Johnson & Johnson Services, Inc., Glaxosmithkline Plc., Bayer Ag, Mylan N.V., Boehringer Ingelheim International Gmbh, Hisamitsu Pharmaceutical Co.,Inc., Luye Pharma Group, Purdue Pharma L.P., and Lavipharm among others. Several organic approaches, such as product launches, and expansion in the transdermal drug delivery system market, have resulted in the positive growth of the market. Product launches help the company to strengthen its product offering and the customer base, which allows the company to hold a strong position in the market. Similarly, utilizing expansion activities, it is easy to venture into untapped economies and use the opportunities being offered.
The report segments global transdermal drug delivery system market as follows:
- Transdermal Patches
- Matrix Patches
- Microneedle Patches
- Drug-In-Adhesive Patches
- Reservoir Membrane Patches
- Transdermal Semisolids
- Cardiovascular Diseases
- Central Nervous System Disorders
- Pain Management
- Hormonal Applications
- Transdermal Estrogen Therapy
- Testosterone Replacement Therapy
- Other Applications
By End User
- Hospitals and Clinics
- Home Care Settings
- Other End Users
- North America
- Asia Pacific (APAC)
- Middle East and Africa (MEA)
- South and Central America
Transdermal Drug Delivery System (TDDS) is described as a self-contained or discrete dosage form known as patches or semisolid forms that are applied to the intact skin. There are different types of semisolid forms, such as, creams, ointments, gels, sprays and others. Dosage forms are designed to deliver a therapeutically effective amount of drug across a patient’s skin. The market for transdermal drug delivery system is expected to witness huge growth due to growing demand for noninvasive medical devices along with the increasing prevalence of chronic diseases.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]